India, Aug. 19 -- Jiangsu Hengrui Pharmaceuticals Co.Ltd (1276.HK) reported earnings for first half of RMB4.465 billion
The company's bottom line came in at RMB4.465 billion, or RMB0.68 per share. This compares with RMB4.450 billion, or RMB0.70 per share, last year.
The company's revenue for the period fell 1.9% to RMB15.455 billion from RMB15.761 billion last year.
Jiangsu Hengrui Pharmaceuticals Co.Ltd earnings at a glance (GAAP) :
-Earnings: RMB4.465 Bln. vs. RMB4.450 Bln. last year.-EPS: RMB0.68 vs. RMB0.70 last year.-Revenue: RMB15.455 Bln vs. RMB15.761 Bln last year.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....